Aehr Test Systems (AEHR) Financial Statements

Income statement

Metric	TTM	2026	2025	2024	2023
Revenue
Total Revenue	50.9M	50.0M	59.0M	66.2M	65.0M
Cost of Revenue	33.3M	32.4M	35.0M	33.7M	32.2M
Gross Profit	17.7M	17.7M	23.9M	32.5M	32.7M
Operating Expenses
R&D Expense	12.6M	12.6M	10.5M	8.7M	7.1M
SG&A Expense	19.2M	19.2M	17.8M	13.7M	12.2M
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	6.0K	6.0K	—	—	—
Total Operating Expenses	31.8M	31.8M	28.2M	22.5M	19.4M
Cost and Expenses	65.1M	64.2M	63.3M	56.1M	51.6M
Operating Income (EBIT)	(14.2M)	(14.1M)	(4.3M)	10.1M	13.4M
Non-Operating
Interest Income	1.4M	1.4M	1.4M	2.4M	1.2M
Interest Expense	—	—	—	—	—
Net Interest Income	1.4M	1.4M	1.4M	2.4M	1.2M
Other Non-Op Income/Expense	2.4M	2.4M	22.0K	2.4M	1.2M
Non-Operating Income (excl Interest)	(2.4M)	(2.4M)	(22.0K)	(2.4M)	(1.2M)
EBT (Pre-Tax Income)	(11.7M)	(11.7M)	(4.3M)	12.5M	14.6M
Income Tax Expense	(4.6M)	(4.6M)	(381.0K)	(20.7M)	60.0K
Bottom Line
Net Income	(7.1M)	(7.1M)	(3.9M)	33.2M	14.6M
Earnings from Cont. Ops	(7.1M)	(7.1M)	(3.9M)	33.2M	14.6M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(7.1M)	(7.1M)	(3.9M)	33.2M	14.6M
Per Share
Basic EPS	($0.23)	($0.23)	($0.13)	$1.15	$0.52
Diluted EPS	($0.23)	($0.23)	($0.13)	$1.12	$0.50
Revenue Per Share	$1.66	$1.63	$1.99	$2.30	$2.34
Shares
Basic Shares Outstanding	30.7M	30.7M	29.6M	28.8M	27.8M
Diluted Shares Outstanding	30.7M	30.7M	29.6M	29.6M	29.2M
Profitability Metrics
EBITDA	(11.7M)	(11.7M)	(903.0K)	13.8M	15.1M
D&A	—	—	3.4M	1.4M	450.0K
EBIT	(11.7M)	(11.7M)	(4.3M)	12.5M	14.6M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of May 1, 2026